FDA Approved: TARGRETIN — Supplemental Application (Bausch Health US, LLC)

View source ↗

Summary

The FDA approved a supplemental application for TARGRETIN (bexarotene) submitted by Bausch Health US, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous T-cell Lymphoma
• Mycosis Fungoides
• Sezary Syndrome

Drugs mentioned

• Targretin (bexarotene)

Snippet

SUPPL AP for TARGRETIN (BEXAROTENE)